NCT01476501View on ClinicalTrials.gov

Vitamin D Supplementation in Diabetic Nephropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions

Sub-optimal Vitamin D StatusBone DiseaseDiabetic Nephropathy

Interventions

DRUG

Vitamin D3

Randomized into 1 of 2 oral vitamin D3 softgel capsule supplementation strategies: 1) 2,000 IU/day (2 x 1,000IU/capsule each day) or 2) 40,000 IU/month (4 x 10,000IU/capsule last day of each month), for 6 months each.

Trial Locations (1)

T6G 0K2

Clinical Research Unit, University of Alberta, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER

NCT01476501 - Vitamin D Supplementation in Diabetic Nephropathy | Biotech Hunter | Biotech Hunter